Product Description A new long-acting glucagon-like peptide-1 (GLP-1) analogue from Novo Nordisk for glycemic control in adults with type 2 diabetes who have received and/or sulfonylureas in addition to diet control and exercise. And reduce the risk of major cardiovascular adverse events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes with cardiovascular disease. MOQ: 1 piece delivery time : within 3-5 days delivery terms : DHL,EMS ,FEDEX and so on . After sale : online 24h
Looks like there are no reviews for this Product
Looks like there are no reviews for this product
China
We are a manufacturer and exporter of dermal fillers and a wide range of beauty and aesthetic products. As a dermal filler producer, we ensure high-quality standards, safety, and consistency across all our products for international markets.
A virtual marketplace leading your business into the future
